Heron Therapeutics, Inc. Gains 59.26%
Wed, Nov 15, 2023 at 07:48 PM
Heron Therapeutics, Inc. (HRTX:NASDAQ) soared at $0.86, representing a gain of 59.3%. On Wed, Nov 15, 2023, HRTX:NASDAQ hit a New 2-Week High of $0.86. The stock got featured on our News Catalysts scanner on Wed, Nov 15, 2023 at 12:36 PM in the 'MISCELLANEOUS' category. From Wed, Nov 01, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Aug 10, 2023 at $1.87 with a volume of 2M+.
About Heron Therapeutics, Inc. (HRTX:NASDAQ)
Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.
Top 10 Gainers:
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 83.64%
- MIRA Pharmaceuticals Inc. (MIRA:NASDAQ), 72.51%
- Heron Therapeutics, Inc. (HRTX:NASDAQ), 59.26%
- Kinnate Biopharma Inc. (KNTE:NASDAQ), 59.24%
- Ebix, Inc. (EBIX:NASDAQ), 57.66%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 50%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 49.7%
- SciSparc Ltd. (SPRC:NASDAQ), 48.17%
- The Beauty Health Company (SKIN:NASDAQ), 36.69%
- ZK International Group Co., Ltd. (ZKIN:NASDAQ), 36.27%